Concerning mutant EGFR and mutant BRAFs, two studies have been inspired so far by the emergence of BRAFV600E in treatment-refractory EGFRL858R lung cancers as they become resistant to EGFR-targeted therapies177,179. This evidence concerns the gene EGFR and lung carcinoma.